Skip to main content

Table 2 Demographic characteristics of 279 medical cannabis patients, by symptom group

From: Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic

  Sample size (percentage) Number of female patients (percentage) Mean age (SD)
Overall sample 279 190 (68) 61.1 (16.6)
Moderate or severe pain symptom group 205 (73.5) 150 (73) 61.8 (15.9)
Moderate or severe anxiety symptom group 138 (48.5) 97 (70) 61.43 (16.3)
Moderate or severe depression symptom group 115 (41.2) 81 (70) 60.5 (15)
Moderate or severe wellbeing group 202 (72.4) 141 (70) 60.8 (16.1)
CBD/THC:CBD group 116 (41.6) 75 (65) 60.38 (14.4)
  1. The symptom groups are mild and moderate or severe. The table presents the moderate or severe demographic characteristics. The CBD/THC:CBD group is composed of patients who added THC to their CBD-rich prescription during FUP1
  2. CBD cannabidiol, THC Δ9-tetrahydrocannabinol, SD standard deviation